Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Hepion Pharmaceuticals, Inc.

OTC: HEPA · Life Sciences · 4 alerts · CIK 1583771

Share price
$0.0903Close, Nov 16
Market cap
$11.3M
Shares outstanding
125.07MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Hepion Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:31 PM ET 10-Q
Financial Results

Hepion Pharmaceuticals Q3 2026 Results: Net Loss of $4.58M, Loss Widens

Hepion Pharmaceuticals reported a net loss of $6.6 million for the nine months ended September 30, 2026, compared to a $7.6 million loss in the prior year period. The company's financial position shows a stockholders' deficit of $4.0 million, and management highlighted significant uncertainties regarding their ability to raise additional capital to continue as a going concern.

Key figure
Net loss $4.58M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.